![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in United States FDA approves first generic GLP-1](https://photos.prnewswire.com/prnfull/20150421/200096)
evaluate the pharmaceuticals company saxenda on glp-1 medications
Shipping Estimate
evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in United States FDA approves first generic GLP-1
USD25.34
USD72.34
Pay in 4 interest-free payments of $6.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA approves first generic GLP-1](https://www.singlecare.com/blog/wp-content/uploads/2025/09/FDA_approval_Saxenda.png)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA approves first generic GLP-1](https://www.singlecare.com/blog/wp-content/uploads/2026/01/saxenda-generic-600x338.png)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA approves first generic GLP-1](https://lifestylemedicalcenters.com/wp-content/uploads/2022/06/Saxenda-Pen.jpg)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA approves first generic GLP-1](https://missouripoisoncenter.org/wp-content/uploads/2024/12/iStock-2025836701-1.webp)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA approves first generic GLP-1](https://insights.citeline.com/resizer/v2/TSZ7GUC53NHWVPONFRWK5ATONE.jpg?smart=true&auth=63b90fd60c1f7cd8d70dec77ef6e370667db1ebf65eb042c406b01746595fece&width=700&height=394)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA approves first generic GLP-1](https://pharmaceutical-journal.com/wp-content/uploads/2025/09/Feature_GLP1.png)
-1775582746855.png&w=384&q=75)
